Nanjing Well Pharmaceutical Group (603351.SH) plans to repurchase company shares for RMB 50 million to RMB 100 million.

Nanjing Well Pharmaceutical Group (603351.SH) announced that the company plans to repurchase its shares using its own funds or self-raised funds (including special loans for share repurchases) for the future implementation of an employee stock ownership plan or equity incentives. The repurchase amount shall be no less than RMB 50 million (inclusive) and no more than RMB 100 million (inclusive), and the repurchase price shall not exceed RMB 40.11 per share (inclusive). The repurchase period shall be within 12 months from the date the board of directors approves this repurchase plan.